XLO
USDXilio Therapeutics Inc. Common Stock
$0.802-0.048 (-5.671%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.850
High
$0.858
Low
$0.793
Volume
1.10M
Company Fundamentals
Market Cap
41.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.67M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.615Current $0.802High $1.7
Related News
GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living
View more
GlobeNewswire
Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting
WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.